CN110412294B9 - 蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法 - Google Patents
蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法 Download PDFInfo
- Publication number
- CN110412294B9 CN110412294B9 CN201910725954.1A CN201910725954A CN110412294B9 CN 110412294 B9 CN110412294 B9 CN 110412294B9 CN 201910725954 A CN201910725954 A CN 201910725954A CN 110412294 B9 CN110412294 B9 CN 110412294B9
- Authority
- CN
- China
- Prior art keywords
- protein
- calibrator
- stabilizing solution
- proteins
- anionic surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 265
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 265
- 230000000087 stabilizing effect Effects 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 32
- 239000000243 solution Substances 0.000 claims abstract description 79
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 56
- 239000000872 buffer Substances 0.000 claims abstract description 26
- 229920005862 polyol Polymers 0.000 claims abstract description 24
- 150000003077 polyols Chemical class 0.000 claims abstract description 24
- 239000003085 diluting agent Substances 0.000 claims abstract description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 44
- 238000001514 detection method Methods 0.000 claims description 40
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 102000003802 alpha-Synuclein Human genes 0.000 claims description 16
- 108090000185 alpha-Synuclein Proteins 0.000 claims description 16
- JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 claims description 14
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims description 10
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims description 10
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical group [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 claims description 8
- 238000001917 fluorescence detection Methods 0.000 claims description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- 239000007995 HEPES buffer Substances 0.000 claims description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 4
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000007983 Tris buffer Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 230000001900 immune effect Effects 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000002776 aggregation Effects 0.000 abstract description 22
- 238000004220 aggregation Methods 0.000 abstract description 15
- 239000007853 buffer solution Substances 0.000 abstract description 12
- 150000005846 sugar alcohols Polymers 0.000 abstract description 12
- 238000003860 storage Methods 0.000 abstract description 10
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 9
- 239000001257 hydrogen Substances 0.000 abstract description 9
- 230000004845 protein aggregation Effects 0.000 abstract description 8
- 238000005054 agglomeration Methods 0.000 abstract description 7
- 230000007774 longterm Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 7
- 229920000642 polymer Polymers 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 238000004925 denaturation Methods 0.000 abstract description 4
- 230000036425 denaturation Effects 0.000 abstract description 4
- 230000036571 hydration Effects 0.000 abstract description 4
- 238000006703 hydration reaction Methods 0.000 abstract description 4
- 108010064539 amyloid beta-protein (1-42) Proteins 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 239000002585 base Substances 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 17
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 16
- 235000011187 glycerol Nutrition 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 239000004094 surface-active agent Substances 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 238000003018 immunoassay Methods 0.000 description 9
- 229910052783 alkali metal Inorganic materials 0.000 description 8
- 150000001340 alkali metals Chemical class 0.000 description 8
- 125000001183 hydrocarbyl group Chemical group 0.000 description 8
- 235000002639 sodium chloride Nutrition 0.000 description 8
- 229910019142 PO4 Inorganic materials 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 7
- 150000007942 carboxylates Chemical class 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 7
- 239000010452 phosphate Substances 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 2
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 2
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 2
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 108010064397 amyloid beta-protein (1-40) Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- -1 organic acid salt Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical group [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- QDSWHSQBAUPQGK-UHFFFAOYSA-K trisodium;dodecyl hydrogen phosphate;dodecyl phosphate Chemical group [Na+].[Na+].[Na+].CCCCCCCCCCCCOP(O)([O-])=O.CCCCCCCCCCCCOP([O-])([O-])=O QDSWHSQBAUPQGK-UHFFFAOYSA-K 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
- QYYMDNHUJFIDDQ-UHFFFAOYSA-N 5-chloro-2-methyl-1,2-thiazol-3-one;2-methyl-1,2-thiazol-3-one Chemical compound CN1SC=CC1=O.CN1SC(Cl)=CC1=O QYYMDNHUJFIDDQ-UHFFFAOYSA-N 0.000 description 1
- LEOJISUPFSWNMA-UHFFFAOYSA-N ABEI Chemical compound O=C1NNC(=O)C=2C1=CC(N(CCCCN)CC)=CC=2 LEOJISUPFSWNMA-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 230000003518 presynaptic effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940124272 protein stabilizer Drugs 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
实施例1 | 实施例2 | 实施例3 | 对比例1 | |
37℃稳定性 | 相对荧光强度 | 相对荧光强度 | 相对荧光强度 | 相对荧光强度 |
第0天 | 115 | 120 | 111 | 143 |
第1天 | 165 | 189 | 118 | 357 |
第2天 | 208 | 234 | 124 | 569 |
第3天 | 254 | 288 | 127 | 789 |
第4天 | 304 | 312 | 126 | 833 |
第5天 | 357 | 343 | 128 | 921 |
第6天 | 382 | 411 | 124 | 1011 |
第7天 | 423 | 452 | 128 | 1069 |
长期稳定性 | 相对荧光强度 | 相对荧光强度 | 相对荧光强度 | 相对荧光强度 |
第0月 | 111 | 113 | 109 | 143 |
第1月 | 130 | 163 | 111 | 426 |
第3月 | 188 | 202 | 117 | 612 |
第5月 | 208 | 241 | 116 | 758 |
第7月 | 246 | 293 | 120 | 885 |
第9月 | 302 | 333 | 122 | 985 |
第11月 | 346 | 374 | 126 | 1022 |
第12月 | 389 | 423 | 133 | 1235 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910725954.1A CN110412294B9 (zh) | 2019-08-07 | 2019-08-07 | 蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910725954.1A CN110412294B9 (zh) | 2019-08-07 | 2019-08-07 | 蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
CN110412294A CN110412294A (zh) | 2019-11-05 |
CN110412294B CN110412294B (zh) | 2023-03-28 |
CN110412294B9 true CN110412294B9 (zh) | 2023-05-26 |
Family
ID=68366261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910725954.1A Active CN110412294B9 (zh) | 2019-08-07 | 2019-08-07 | 蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110412294B9 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020075692A1 (ja) * | 2018-10-09 | 2020-04-16 | 積水メディカル株式会社 | ロイシンリッチα2グリコプロテイン組成物 |
CN111208309B (zh) * | 2020-01-07 | 2022-05-03 | 郑州安图生物工程股份有限公司 | 一种促甲状腺素受体冻干品的溶解液及复溶方法 |
CN114324882B (zh) * | 2020-10-12 | 2022-12-27 | 广东菲鹏生物有限公司 | 蛋白稳定剂及其应用 |
CN114652866A (zh) * | 2020-12-23 | 2022-06-24 | 上海其胜生物制剂有限公司 | 一种羧甲基几丁质溶液的湿热灭菌方法 |
CN117700525B (zh) * | 2024-02-05 | 2024-06-18 | 上海良润生物医药科技有限公司 | 一种多肽改造体及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0675126A1 (en) * | 1993-10-20 | 1995-10-04 | Teijin Limited | Amyloid beta-protein agglutination and/or deposition inhibitor |
DE10303974A1 (de) * | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
JP2006206584A (ja) * | 2004-12-27 | 2006-08-10 | Tohoku Univ | アミロイドβ蛋白の凝集抑制剤、凝集アミロイドβ蛋白の分解剤、抗痴呆薬および抗痴呆性食品 |
TW200726774A (en) * | 2005-06-30 | 2007-07-16 | Merck & Co Inc | Composition and method for producing stable amyloid beta oligomers |
WO2011149917A1 (en) * | 2010-05-25 | 2011-12-01 | Adlyfe, Inc. | STABILIZED AMYLOID- β OLIGOMERS AND USES THEREOF |
JP2017532289A (ja) * | 2014-07-07 | 2017-11-02 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用 |
CN105628914B (zh) * | 2016-02-04 | 2019-01-08 | 广州科方生物技术股份有限公司 | 一种能使吖啶酯抗原抗体结合物稳定的稀释液及其制备方法 |
US20170349641A1 (en) * | 2016-06-02 | 2017-12-07 | The Regents Of The University Of Calfornia | Chiral Substituted Amyloid Beta Peptides |
CN108267579B (zh) * | 2016-12-30 | 2020-10-20 | 深圳市新产业生物医学工程股份有限公司 | 稳定保存稀释液、抗核抗体检测试剂及其制备方法和应用 |
CN109212180B (zh) * | 2018-10-19 | 2021-10-12 | 广东菲鹏生物有限公司 | 用于小分子抗原与碱性磷酸酶标记结合物的保存液及其制备方法 |
-
2019
- 2019-08-07 CN CN201910725954.1A patent/CN110412294B9/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110412294A (zh) | 2019-11-05 |
CN110412294B (zh) | 2023-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110412294B9 (zh) | 蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法 | |
US20230068749A1 (en) | Stabilization of aqueous compositions of proteins with displacement buffers | |
CA2614006C (en) | Stable aqueous systems comprising proteins | |
Benson et al. | Design, synthesis, and circular dichroism investigation of a peptide-sandwiched mesoheme | |
ITTO940106A1 (it) | Composizione stabilizzata di troponina per saggi immunologici e procedimento di stabilizzazione di troponina per saggi immunologici | |
Rodrı́guez-Crespo et al. | Binding of dynein light chain (PIN) to neuronal nitric oxide synthase in the absence of inhibition | |
US20150329605A1 (en) | Method for stabilizing protein | |
CN112710825A (zh) | 碱性磷酸酶酶标缓冲液和碱性磷酸酶酶标试剂 | |
EP2088434A1 (en) | Pyrocatechol violet-metal protein assay | |
CN108409852B (zh) | 性激素结合球蛋白保存液以及其应用 | |
WO2006121064A1 (ja) | 肺サーファクタント蛋白質の安定化法 | |
JP2000258420A (ja) | 溶液中のヒトヘモグロビンの安定化方法および安定化溶液 | |
US9879250B2 (en) | Protein-stabilizing agent and protein-stabilizing method | |
CN112851786B (zh) | 可溶性的Aβ1-42变体、Aβ1-42校准品及试剂盒 | |
WO2019168109A1 (ja) | 検体中に含まれる蛋白質を安定化する方法、検体中に含まれる蛋白質を安定化させるための溶液 | |
JP4568334B2 (ja) | 抗原含有水溶液 | |
JPH11218533A (ja) | ヘモグロビン試料の安定化 | |
CN107602687B (zh) | 肌钙蛋白的保存剂及保存组合物 | |
CN107602695B (zh) | 荧光抗体保存液、试剂盒及其用途和荧光保存抗体方法 | |
DE19502386A1 (de) | Stabilisierung von Peptiden und Polypeptiden in immunologischen Tests durch Zusatz von kleinen Hitzeschockproteinen | |
JP2010091398A (ja) | 安定なナトリウム利尿ペプチド組成物 | |
CN117705549A (zh) | 一种蛋白保护剂、稀释液和应用 | |
CN117288939A (zh) | 抗体纳米磁珠包被物及其制备方法与应用 | |
JP2016011310A (ja) | タンパク質の安定化剤 | |
JPH0980050A (ja) | 酵素標識抗体溶液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CI03 | Correction of invention patent |
Correction item: Denomination of Invention|Description Correct: Protein stabilizers, protein calibrators, reagent kits, and methods for detecting the stability of protein calibrators|Paragraphs 1-127 of the specification submitted on April 28, 2023 False: Protein stabilizer, protein calibrator, reagent kit, and methods for detecting the stability of protein standards|Paragraphs 1-127 of the specification submitted on the application date Number: 13-01 Page: ?? Volume: 39 Correction item: Denomination of Invention Correct: Protein stabilizers, protein calibrators, reagent kits, and methods for detecting the stability of protein calibrators False: Protein stabilizer, protein calibrator, reagent kit, and methods for detecting the stability of protein standards Number: 13-01 Volume: 39 |
|
CI03 | Correction of invention patent | ||
OR01 | Other related matters | ||
OR01 | Other related matters |